English

BIONX IMPLANTS INC

EDGAR

Quarterly report (10-Q) · filed 2002-11-14

29 filing records in this dataset, filed from 1997-06-09 to 2002-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.3 million USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 4301000 USD Source

Operating margin

-10.49%

2002-09-30 · %

Exact inputs and evidence

Operating Income: -451000 USD Source
Revenue: 4301000 USD Source

Operating cash flow

38 thousand USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 132000 USD Source
Operating Cash Flow: 94000 USD Source

Free cash flow

-227 thousand USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 132000 USD Source
Operating Cash Flow: 94000 USD Source
Capital Expenditure: 466000 USD Source
Capital Expenditure: 201000 USD Source

Cash and cash equivalents: 4.53 million USD 2002-09-30 Source
Exact value

4534000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.3 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 18887719 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 14210000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 4766000 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 4561000 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 4301000 USD · 2002-07-01 – 2002-09-30 Source

Net income

-470 thousand USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -2481298 USD · 2001-01-01 – 2001-12-31 Source
Net income: -2668000 USD · 2001-01-01 – 2001-09-30 Source
Net income: 82000 USD · 2002-01-01 – 2002-03-31 Source
Net income: -298000 USD · 2002-04-01 – 2002-06-30 Source
Net income: -441000 USD · 2002-07-01 – 2002-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-11-14.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2001-12-31
Operating income: 7 of 11 periods available· newest 2001-12-31
Net income: 7 of 11 periods available· newest 2001-12-31
Operating cash flow: 7 of 11 periods available· newest 2001-12-31
Capital expenditure: 7 of 11 periods available· newest 2001-12-31
Total assets: 6 of 11 periods available· newest 2001-12-31
Total liabilities: 4 of 11 periods available· newest 2001-12-31
Current assets: 6 of 11 periods available· newest 2001-12-31
Current liabilities: 6 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.6%

Prior period

USD 18.23 million

2000-01-01 – 2000-12-31
Current period

USD 18.89 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

18887719 − 18231784 = 655935 USD

18231784 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
18887719 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Year-over-year change in Revenue: 655935 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 18887719 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#2946 Input fundies:Revenue: 18231784 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#2946
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.13 million

Prior period

−USD 4.61 million

2000-01-01 – 2000-12-31
Current period

−USD 2.48 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-2481298 − -4608643 = 2127345 USD

-4608643 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-2481298 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Year-over-year change in Net income: 2127345 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2481298 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3074 Input fundies:NetIncome: -4608643 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3074
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-2,051.3%

Prior period

USD 70,919

2000-01-01 – 2000-12-31
Current period

−USD 1.38 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-1383844 − 70919 = -1454763 USD

70919 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-1383844 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Year-over-year change in Operating cash flow: -1454763 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1383844 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 Input fundies:OperatingCashFlow: 70919 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+163.4%

Prior period

USD 251,702

2000-01-01 – 2000-12-31
Current period

USD 662,903

2001-01-01 – 2001-12-31

Exact inputs and evidence

662903 − 251702 = 411201 USD

251702 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
662903 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Year-over-year change in Capital expenditure: 411201 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 662903 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 Input fundies:CapitalExpenditure: 251702 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 18.89 million 100% of revenue
Cost of revenue USD 5.93 million 31% of revenue
Operating expenses USD 15.63 million 83% of revenue
Operating income −USD 2.67 million −14% of revenue
Tax, interest and other Derived −USD 187,691 −1% of revenue
Net income −USD 2.48 million −13% of revenue

Cash

Operating cash flow −USD 1.38 million −7.3% of revenue
Capital expenditure USD 662,903 3.5% of revenue
Free cash flow Derived −USD 2.05 million −11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 184% of revenue.
1996 Operating loss: operating costs were 187% of revenue.
1997 Net income was higher than operating income, so the split is not drawn.
1998 Net income was higher than operating income, so the split is not drawn.
1999 Operating loss: operating costs were 162% of revenue.
2000 Operating loss: operating costs were 125% of revenue.
2001 Operating loss: operating costs were 114% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	1621606	2976566 Derived	-1354960	123056 Derived	-1478016	-1592668 Derived	Source 1995-01-01 – 1995-12-31: 1621606 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -1354960 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -1478016 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -1555352 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 37316 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	5379155	10033183 Derived	-4654028	338247 Derived	-4992275	-2923651 Derived	Source 1996-01-01 – 1996-12-31: 5379155 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -4654028 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -4992275 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -2842061 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 81590 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	16014359	14257602 Derived	1756757	-401606 Derived	2158363	744096 Derived	Source 1997-01-01 – 1997-12-31: 16014359 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 1756757 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: 2158363 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 1156359 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 412263 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	21100472	19847318 Derived	1253154	-8191 Derived	1261345	-7817402 Derived	Source 1998-01-01 – 1998-12-31: 21100472 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 1253154 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 1261345 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -5773131 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2044271 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	21068164	34181801 Derived	-13113637	-650524 Derived	-12463113	-10541802 Derived	Source 1999-01-01 – 1999-12-31: 21068164 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -13113637 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -12463113 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -9349366 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1192436 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	18231784	22707175 Derived	-4475391	133252 Derived	-4608643	-180783 Derived	Source 2000-01-01 – 2000-12-31: 18231784 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -4475391 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -4608643 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 70919 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 251702 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	18887719	21556708 Derived	-2668989	-187691 Derived	-2481298	-2046747 Derived	Source 2001-01-01 – 2001-12-31: 18887719 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -2668989 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -2481298 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -1383844 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 662903 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 18.9M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	1621606	Revenue: 1621606 Open source
19961996-12-31	Revenue	5379155	Revenue: 5379155 Open source
19971997-12-31	Revenue	16014359	Revenue: 16014359 Open source
19981998-12-31	Revenue	21100472	Revenue: 21100472 Open source
19991999-12-31	Revenue	21068164	Revenue: 21068164 Open source
20002000-12-31	Revenue	18231784	Revenue: 18231784 Open source
20012001-12-31	Revenue	18887719	Revenue: 18887719 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.6% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 1621606 Open source
19961996-12-31	Year over year	231.7%	Revenue: 5379155 Open source Revenue: 1621606 Open source
19971997-12-31	Year over year	197.7%	Revenue: 16014359 Open source Revenue: 5379155 Open source
19981998-12-31	Year over year	31.8%	Revenue: 21100472 Open source Revenue: 16014359 Open source
19991999-12-31	Year over year	-0.2%	Revenue: 21068164 Open source Revenue: 21100472 Open source
20002000-12-31	Year over year	-13.5%	Revenue: 18231784 Open source Revenue: 21068164 Open source
20012001-12-31	Year over year	3.6%	Revenue: 18887719 Open source Revenue: 18231784 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -14.1% 2001

Net margin -13.1% 2001

Free cash flow margin -10.8% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-83.6%	Operating Income: -1354960 Open source Revenue: 1621606 Open source
19961996-12-31	Operating margin	-86.5%	Operating Income: -4654028 Open source Revenue: 5379155 Open source
19971997-12-31	Operating margin	11%	Operating Income: 1756757 Open source Revenue: 16014359 Open source
19981998-12-31	Operating margin	5.9%	Operating Income: 1253154 Open source Revenue: 21100472 Open source
19991999-12-31	Operating margin	-62.2%	Operating Income: -13113637 Open source Revenue: 21068164 Open source
20002000-12-31	Operating margin	-24.5%	Operating Income: -4475391 Open source Revenue: 18231784 Open source
20012001-12-31	Operating margin	-14.1%	Operating Income: -2668989 Open source Revenue: 18887719 Open source
19951995-12-31	Net margin	-91.1%	Net Income: -1478016 Open source Revenue: 1621606 Open source
19961996-12-31	Net margin	-92.8%	Net Income: -4992275 Open source Revenue: 5379155 Open source
19971997-12-31	Net margin	13.5%	Net Income: 2158363 Open source Revenue: 16014359 Open source
19981998-12-31	Net margin	6%	Net Income: 1261345 Open source Revenue: 21100472 Open source
19991999-12-31	Net margin	-59.2%	Net Income: -12463113 Open source Revenue: 21068164 Open source
20002000-12-31	Net margin	-25.3%	Net Income: -4608643 Open source Revenue: 18231784 Open source
20012001-12-31	Net margin	-13.1%	Net Income: -2481298 Open source Revenue: 18887719 Open source
19951995-12-31	Free cash flow margin	-98.2%	Revenue: 1621606 Open source Operating Cash Flow: -1555352 Open source Capital Expenditure: 37316 Open source
19961996-12-31	Free cash flow margin	-54.4%	Revenue: 5379155 Open source Operating Cash Flow: -2842061 Open source Capital Expenditure: 81590 Open source
19971997-12-31	Free cash flow margin	4.6%	Revenue: 16014359 Open source Operating Cash Flow: 1156359 Open source Capital Expenditure: 412263 Open source
19981998-12-31	Free cash flow margin	-37%	Revenue: 21100472 Open source Operating Cash Flow: -5773131 Open source Capital Expenditure: 2044271 Open source
19991999-12-31	Free cash flow margin	-50%	Revenue: 21068164 Open source Operating Cash Flow: -9349366 Open source Capital Expenditure: 1192436 Open source
20002000-12-31	Free cash flow margin	-1%	Revenue: 18231784 Open source Operating Cash Flow: 70919 Open source Capital Expenditure: 251702 Open source
20012001-12-31	Free cash flow margin	-10.8%	Revenue: 18887719 Open source Operating Cash Flow: -1383844 Open source Capital Expenditure: 662903 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.4M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-1555352	Operating Cash Flow: -1555352 Open source
19961996-12-31	Operating cash flow	-2842061	Operating Cash Flow: -2842061 Open source
19971997-12-31	Operating cash flow	1156359	Operating Cash Flow: 1156359 Open source
19981998-12-31	Operating cash flow	-5773131	Operating Cash Flow: -5773131 Open source
19991999-12-31	Operating cash flow	-9349366	Operating Cash Flow: -9349366 Open source
20002000-12-31	Operating cash flow	70919	Operating Cash Flow: 70919 Open source
20012001-12-31	Operating cash flow	-1383844	Operating Cash Flow: -1383844 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-1592668	Operating Cash Flow: -1555352 Open source Capital Expenditure: 37316 Open source
19961996-12-31	Free cash flow	-2923651	Operating Cash Flow: -2842061 Open source Capital Expenditure: 81590 Open source
19971997-12-31	Free cash flow	744096	Operating Cash Flow: 1156359 Open source Capital Expenditure: 412263 Open source
19981998-12-31	Free cash flow	-7817402	Operating Cash Flow: -5773131 Open source Capital Expenditure: 2044271 Open source
19991999-12-31	Free cash flow	-10541802	Operating Cash Flow: -9349366 Open source Capital Expenditure: 1192436 Open source
20002000-12-31	Free cash flow	-180783	Operating Cash Flow: 70919 Open source Capital Expenditure: 251702 Open source
20012001-12-31	Free cash flow	-2046747	Operating Cash Flow: -1383844 Open source Capital Expenditure: 662903 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

19.7% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	No source recorded
1996-12-31	Liabilities / assets	Not reported	Total Assets: 9369749 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 33540981 Open source
19981998-12-31	Liabilities / assets	18.2%	Total Liabilities: 6708432 Open source Total Assets: 36949048 Open source
19991999-12-31	Liabilities / assets	23.2%	Total Liabilities: 5427169 Open source Total Assets: 23421175 Open source
20002000-12-31	Liabilities / assets	21%	Total Liabilities: 4648265 Open source Total Assets: 22178735 Open source
20012001-12-31	Liabilities / assets	19.7%	Total Liabilities: 3698000 Open source Total Assets: 18815000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.03× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Current assets / current liabilities	Not reported	No source recorded
19961996-12-31	Current assets / current liabilities	1.74×	Current Assets: 4803069 Open source Current Liabilities: 2756609 Open source
19971997-12-31	Current assets / current liabilities	6.65×	Current Assets: 28893462 Open source Current Liabilities: 4344400 Open source
19981998-12-31	Current assets / current liabilities	4.79×	Current Assets: 30617412 Open source Current Liabilities: 6385510 Open source
19991999-12-31	Current assets / current liabilities	3.26×	Current Assets: 16669166 Open source Current Liabilities: 5113105 Open source
20002000-12-31	Current assets / current liabilities	3.71×	Current Assets: 16034225 Open source Current Liabilities: 4317204 Open source
20012001-12-31	Current assets / current liabilities	4.03×	Current Assets: 12926000 Open source Current Liabilities: 3204000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 1.48 million Exact value Exact value: -1478016 USD 1995-01-01 – 1995-12-31: -1478016 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 1995-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: -1478016 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1478016 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-98-000199.txt#2560 The citation records this snapshot. The page link may show a newer release later.	−USD 1.56 million Exact value Exact value: -1555352 USD 1995-01-01 – 1995-12-31: -1555352 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 1995-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: -1555352 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1555352 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-98-000199.txt#2589 The citation records this snapshot. The page link may show a newer release later.	USD 37,316 Exact value Exact value: 37316 USD 1995-01-01 – 1995-12-31: 37316 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 1995-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 37316 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37316 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-98-000199.txt#2593 The citation records this snapshot. The page link may show a newer release later.	−USD 1.59 million Calculation and evidence -1555352 − 37316 USD Exact free cash flow: -1592668 USD 1995-01-01 – 1995-12-31: -1555352 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 37316 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 1995-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -1592668 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1555352 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-98-000199.txt#2589 Input fundies:CapitalExpenditure: 37316 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-98-000199.txt#2593 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 4.99 million Exact value Exact value: -4992275 USD 1996-01-01 – 1996-12-31: -4992275 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 1996-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: -4992275 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4992275 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-99-000215.txt#2709 The citation records this snapshot. The page link may show a newer release later.	−USD 2.84 million Exact value Exact value: -2842061 USD 1996-01-01 – 1996-12-31: -2842061 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 1996-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: -2842061 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2842061 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-99-000215.txt#2739 The citation records this snapshot. The page link may show a newer release later.	USD 81,590 Exact value Exact value: 81590 USD 1996-01-01 – 1996-12-31: 81590 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 1996-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 81590 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 81590 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-99-000215.txt#2743 The citation records this snapshot. The page link may show a newer release later.	−USD 2.92 million Calculation and evidence -2842061 − 81590 USD Exact free cash flow: -2923651 USD 1996-01-01 – 1996-12-31: -2842061 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 81590 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 1996-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -2923651 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2842061 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-99-000215.txt#2739 Input fundies:CapitalExpenditure: 81590 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000905718-99-000215.txt#2743 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 2.16 million Exact value Exact value: 2158363 USD 1997-01-01 – 1997-12-31: 2158363 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 1997-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: 2158363 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2158363 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-00-000473.txt#2708 The citation records this snapshot. The page link may show a newer release later.	USD 1.16 million Exact value Exact value: 1156359 USD 1997-01-01 – 1997-12-31: 1156359 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 1997-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: 1156359 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1156359 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-00-000473.txt#2736 The citation records this snapshot. The page link may show a newer release later.	USD 412,263 Exact value Exact value: 412263 USD 1997-01-01 – 1997-12-31: 412263 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 1997-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 412263 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 412263 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-00-000473.txt#2740 The citation records this snapshot. The page link may show a newer release later.	USD 744,096 Calculation and evidence 1156359 − 412263 USD Exact free cash flow: 744096 USD 1997-01-01 – 1997-12-31: 1156359 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 412263 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 1997-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: 744096 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1156359 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-00-000473.txt#2736 Input fundies:CapitalExpenditure: 412263 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-00-000473.txt#2740 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 1.26 million Exact value Exact value: 1261345 USD 1998-01-01 – 1998-12-31: 1261345 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 1998-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: 1261345 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1261345 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-01-000435.txt#920 The citation records this snapshot. The page link may show a newer release later.	−USD 5.77 million Exact value Exact value: -5773131 USD 1998-01-01 – 1998-12-31: -5773131 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 1998-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: -5773131 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5773131 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-01-000435.txt#946 The citation records this snapshot. The page link may show a newer release later.	USD 2.04 million Exact value Exact value: 2044271 USD 1998-01-01 – 1998-12-31: 2044271 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 1998-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 2044271 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2044271 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-01-000435.txt#974 The citation records this snapshot. The page link may show a newer release later.	−USD 7.82 million Calculation and evidence -5773131 − 2044271 USD Exact free cash flow: -7817402 USD 1998-01-01 – 1998-12-31: -5773131 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2044271 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 1998-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -7817402 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5773131 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-01-000435.txt#946 Input fundies:CapitalExpenditure: 2044271 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0000893220-01-000435.txt#974 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 12.46 million Exact value Exact value: -12463113 USD 1999-01-01 – 1999-12-31: -12463113 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 1999-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: -12463113 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12463113 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3074 The citation records this snapshot. The page link may show a newer release later.	−USD 9.35 million Exact value Exact value: -9349366 USD 1999-01-01 – 1999-12-31: -9349366 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 1999-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: -9349366 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9349366 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Exact value Exact value: 1192436 USD 1999-01-01 – 1999-12-31: 1192436 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 1999-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 1192436 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1192436 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.	−USD 10.54 million Calculation and evidence -9349366 − 1192436 USD Exact free cash flow: -10541802 USD 1999-01-01 – 1999-12-31: -9349366 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1192436 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 1999-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -10541802 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9349366 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 Input fundies:CapitalExpenditure: 1192436 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 4.61 million Exact value Exact value: -4608643 USD 2000-01-01 – 2000-12-31: -4608643 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 2000-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: -4608643 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4608643 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3074 The citation records this snapshot. The page link may show a newer release later.	USD 70,919 Exact value Exact value: 70919 USD 2000-01-01 – 2000-12-31: 70919 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 2000-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: 70919 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 70919 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 The citation records this snapshot. The page link may show a newer release later.	USD 251,702 Exact value Exact value: 251702 USD 2000-01-01 – 2000-12-31: 251702 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 2000-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 251702 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 251702 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.	−USD 180,783 Calculation and evidence 70919 − 251702 USD Exact free cash flow: -180783 USD 2000-01-01 – 2000-12-31: 70919 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 251702 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 2000-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -180783 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 70919 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 Input fundies:CapitalExpenditure: 251702 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 2.48 million Exact value Exact value: -2481298 USD 2001-01-01 – 2001-12-31: -2481298 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Net Income: -2481298 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2481298 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3074 The citation records this snapshot. The page link may show a newer release later.	−USD 1.38 million Exact value Exact value: -1383844 USD 2001-01-01 – 2001-12-31: -1383844 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Operating Cash Flow: -1383844 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1383844 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 The citation records this snapshot. The page link may show a newer release later.	USD 662,903 Exact value Exact value: 662903 USD 2001-01-01 – 2001-12-31: 662903 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Capital Expenditure: 662903 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 662903 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.	−USD 2.05 million Calculation and evidence -1383844 − 662903 USD Exact free cash flow: -2046747 USD 2001-01-01 – 2001-12-31: -1383844 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 662903 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIONX IMPLANTS INC · 2001-12-31 BIONX IMPLANTS INC (edgar:1030418) Free cash flow: -2046747 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030418?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1383844 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3095 Input fundies:CapitalExpenditure: 662903 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030418/0001072613-02-000560.txt#3113 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

29 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001030418, 1030418, edgar:1030418

BIONX IMPLANTS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation